
Research and innovative care for genetic diseases, integrating clinical and research teams to improve patient outcomes.
C
CSR Analysis score
The organization is among the 50% most committed organizations, excluding the top 20%, among comparable organizations.
+160,000
Total organizations analyzedAnalysis by axis
Access the detailed report with all sector benchmarks, in-depth competitive analysis and actionable recommendations.
Methodology: Score calculated according to 6 CSR themes (Carbon, Biodiversity, Circular Economy, Sustainable Investments, Governance, Social Impact)
Sources: Public data, CSR reports, documented initiatives, official databases
Last update: December 2025
This analysis is not yet available in English. Please see the French version.
Leading organizations
Dana-Farber Cancer Institute
B
Specialized cancer treatment and research, including clinical trials and patient-centered care.
Fondation Maladies Rares
B
Coordination and acceleration of research on all rare diseases. Support for excellence research projects, sharing and dissemination of knowledge.
Genethon
B
Research and development of gene therapy medicines for the treatment of rare diseases.
Initiatives identified among leaders
Création d'une initiative pour avancer dans le domaine des soins infirmiers en oncologie
“Dana-Farber Cancer Institute a reçu un don de 10 m...” - Dana-Farber Cancer InstituteFormer et informer sur la recherche sur les maladies rares
“La Fondation Maladies Rares forme et informe sur l...” - Fondation Maladies Raresétude sur l'impact environnemental des décisions de soins de santé
“Dana-Farber Cancer Institute a mené une étude publ...” - Dana-Farber Cancer Institute66% of similar organizations communicate on CSR issues
+2148 initiatives collected from 100 similar organizations
Is your score incomplete? Update your CSR information and improve your positioning.
Claim this page
Updated data
Personalized recommendations
Access complete data, competitive analyses and actionable recommendations for your clients.
Comprehensive sector benchmarks
Competitive data
Ready-to-use reports